We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ON icon
51
ON Semiconductor
ON
$34.7B
$64.4M 0.43%
1,032,164
-111,840
-10% -$7.46M
TXN icon
52
Texas Instruments
TXN
$255B
$64.3M 0.43%
389,068
+81,362
+26% +$13.6M
CVS icon
53
CVS Health
CVS
$137B
$64.1M 0.43%
687,582
-44,969
-6% -$4.34M
MET icon
54
MetLife
MET
$61.2B
$63.4M 0.43%
876,342
+434,814
+98% +$31.1M
SNPS icon
55
Synopsys
SNPS
$74.5B
$60.9M 0.41%
190,859
+49,795
+35% +$15.6M
AMAT icon
56
Applied Materials
AMAT
$410B
$60.1M 0.41%
617,502
+48,989
+9% +$4.7M
PYPL icon
57
PayPal
PYPL
$49.5B
$59.3M 0.4%
833,131
+21,065
+3% +$1.69M
A icon
58
Agilent Technologies
A
$38.9B
$58.9M 0.4%
393,656
-98,296
-20% -$14M
RY icon
59
Royal Bank of Canada
RY
$291B
$58.7M 0.4%
624,629
-88,567
-12% -$8.36M
OC icon
60
Owens Corning
OC
$11.6B
$58.2M 0.39%
682,359
-177,205
-21% -$15.5M
MCD icon
61
McDonald's
MCD
$192B
$56.5M 0.38%
214,466
-35,074
-14% -$9.25M
MS icon
62
Morgan Stanley
MS
$337B
$56.2M 0.38%
661,086
-70,513
-10% -$6.01M
NOW icon
63
ServiceNow
NOW
$109B
$56M 0.38%
720,850
+19,330
+3% +$1.51M
ELV icon
64
Elevance Health
ELV
$82.1B
$55.9M 0.38%
108,989
-2,487
-2% -$1.26M
BMY icon
65
Bristol-Myers Squibb
BMY
$128B
$55.1M 0.37%
765,654
+324,543
+74% +$24.5M
XOM icon
66
ExxonMobil
XOM
$642B
$54.6M 0.37%
495,437
-179,144
-27% -$19.2M
VERU icon
67
Veru
VERU
$36.6M
$53.9M 0.36%
1,021,649
+643,534
+170% +$53M
BMRN icon
68
BioMarin Pharmaceuticals
BMRN
$11.6B
$51.9M 0.35%
501,311
+168,416
+51% +$15.8M
LOW icon
69
Lowe's Companies
LOW
$119B
$51.7M 0.35%
259,690
+1,438
+0.6% +$287K
ILMN icon
70
Illumina
ILMN
$28.7B
$48.9M 0.33%
248,527
-2,884
-1% -$598K
QCOM icon
71
Qualcomm
QCOM
$179B
$48.2M 0.33%
438,519
-114,816
-21% -$13.4M
EQIX icon
72
Equinix
EQIX
$103B
$48.1M 0.32%
73,387
+3,513
+5% +$2.17M
AXP icon
73
American Express
AXP
$229B
$48.1M 0.32%
325,348
+52,864
+19% +$7.83M
SPGI icon
74
S&P Global
SPGI
$130B
$48M 0.32%
143,222
+16,369
+13% +$5.4M
PANW icon
75
Palo Alto Networks
PANW
$259B
$47.2M 0.32%
676,110
-307,236
-31% -$24.7M
1 2
3
4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.